Adalimumab Market Growth, Trend, Price and Forecast to 2024 Adalimumab Market - Global Industry Analysis, Size Haga clic para leer
  • Comentarios

Adalimumab Market Growth, Trend, Price and Forecast to 2024

Adalimumab Market - Global Industry Analysis, Size

Publicado el en “Negocios, Negocios”, Idioma — English. 4 páginas.
Adalimumab, with a trade name of Humira and Exemptia, is an anti-TNF drug used for treating rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, psoriasis and ulcerative colitis. Adalimumab usually binds with tumor necrosis factor-alpha (TNFα). When a TNFα binds to a TBFα receptors, it results in an inflammatory response to autoimmune disease. Más
Adalimumab, with a trade name of Humira and Exemptia, is an anti-TNF drug used for treating rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, psoriasis and ulcerative colitis. Adalimumab usually binds with tumor necrosis factor-alpha (TNFα). When a TNFα binds to a TBFα receptors, it results in an inflammatory response to autoimmune disease. Más
Mostrar Etiquetas
Etiquetas: adalimumab market
Suscríbase GRATIS